The Scientist

» open access and immunology

Most Recent

image: Immune Cells' Roles in Tissue Maintenance and Repair

Immune Cells' Roles in Tissue Maintenance and Repair

By , , and | July 1, 2016

The cells of the mammalian immune system do more than just fight off pathogens; they are also important players in stem cell function and are thus crucial for maintaining homeostasis and recovering from injury.

0 Comments

image: Zika and Dengue Immunity: A Complex Relationship

Zika and Dengue Immunity: A Complex Relationship

By | June 28, 2016

Researchers examine the blood of people infected with dengue virus, finding a few Zika-neutralizing antibodies among mostly enhancing ones.

1 Comment

image: Sex Differences in Immune Response

Sex Differences in Immune Response

By | June 21, 2016

Female mice lacking an immune receptor are better than males at fighting certain viral infections.

0 Comments

image: Breathing Life Into Papers

Breathing Life Into Papers

By | June 12, 2016

Researchers prepare to launch an effort to make the scientific literature more dynamic.

0 Comments

image: E.U. Pushes for Open Access by 2020

E.U. Pushes for Open Access by 2020

By | June 1, 2016

European Union member states agree to an ambitious goal to make all scientific papers freely accessible within four years.

3 Comments

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

3 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Can Plants Learn to Associate Stimuli with Reward?
  4. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

Business Birmingham